The below deals are expired. Umrah packages for 2023 will be updated soon!

Includes:

  • 3-Star, 4-star and 5-Star hotel stay in Makkah and Madinah.
  • Travel to and from hotel and airport with Urdu accommodated by English-speaking drivers.
  • Air tickets and quarantine facility is fully covered as per the package.
  • Guide in English while performing Umrah.
  • Umrah visa with insurance.

Documents:

  • Valid passport with validity of 8 months.
  • Nadra Covid-19 vaccination card with QR code.
  • Passport size picture with light blue background.
  • Original CNIC.
  • Fingerprint biometric. Visa stamping cannot be done without the biometrics. It costs around Rs. 1500/person.
  • Fingerprint biometric. Visa stamping cannot be done without the biometrics. It costs around Rs. 1500/person.

Notes:

  • Packages are non-refundable and non-changeable.
  • All packages are prices are subject to availability.
  • Pilgrims under age of 12 is not allowed to perform Umrah from Pakistan only.
  • Airline will be responsible for changes made in the quarantine package. Sastaticket will not be responsible in case of any discrepancy.
  • Any extension in the quarantine period will not be accommodated in this package.Any extra amount shall be paid by the pilgrim. Sastaticket is not liable for any extra cost.
  • In case if a pilgrim does not get a booking in the hotel mentioned in the package,similar accommodation will be provided to them in terms of hotel stay and distance to and from Haram.
  • The prices mentioned above are valid for the month of March and travel dates should fall between this period i.e till 31st March 2022.
  • PIA, Airblue and Saudi Arabian Airlines currently offer direct flights to Makkah.
  • Two pilgrims in one room. Must register themselves on Quddum platform. Everyone must have Tawwakalna and Etamarna app to attain permit for entering masjids.
  • First 3 days in quarantine if not taken jabs of approved vaccines. Quarantine charges not included in package.
  • Approved vaccines are AstraZeneca, Pfizer, Moderna and Johnson & Johnson’s Janssen.